Cargando…
Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse Model
BACKGROUND: Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disorder characterized by progressive motor and cognitive dysfunction. Caused by an expanded polyglutamine tract in ataxin 1 (ATXN1), SCA1 pathogenesis involves a multifactorial process that likely begins wi...
Autores principales: | Watase, Kei, Gatchel, Jennifer R, Sun, Yaling, Emamian, Effat, Atkinson, Richard, Richman, Ronald, Mizusawa, Hidehiro, Orr, Harry T, Shaw, Chad, Zoghbi, Huda Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1880853/ https://www.ncbi.nlm.nih.gov/pubmed/17535104 http://dx.doi.org/10.1371/journal.pmed.0040182 |
Ejemplares similares
-
Partial Loss of Ataxin-1 Function Contributes to Transcriptional Dysregulation in Spinocerebellar Ataxia Type 1 Pathogenesis
por: Crespo-Barreto, Juan, et al.
Publicado: (2010) -
Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model
por: Aikawa, Tomonori, et al.
Publicado: (2015) -
Cell biology of spinocerebellar ataxia
por: Orr, Harry T.
Publicado: (2012) -
Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1
por: Hatanaka, Yusuke, et al.
Publicado: (2015) -
Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
por: Perroud, Bertrand, et al.
Publicado: (2013)